References
- He JP, Hao Y, Wang XL, Yang XJ, Shao JF, Guo FJ, et al. Review of the molecular pathogenesis of osteosarcoma. Asian Pac J Cancer Prev 2014;15:5967-5976. https://doi.org/10.7314/APJCP.2014.15.15.5967
- Luetke A, Meyers PA, Lewis I, Juergens H. Osteosarcoma treatment - where do we stand? A state of the art review. Cancer Treat Rev 2014;40:523-532. https://doi.org/10.1016/j.ctrv.2013.11.006
- Longhi A, Errani C, De Paolis M, Mercuri M, Bacci G. Primary bone osteosarcoma in the pediatric age: state of the art. Cancer Treat Rev 2006;32:423-436. https://doi.org/10.1016/j.ctrv.2006.05.005
- Smith WL, Garavito RM, DeWitt DL. Prostaglandin endoperoxide H synthases (cyclooxygenases)-1 and -2. J Biol Chem 1996;271:33157-33160. https://doi.org/10.1074/jbc.271.52.33157
- El-Badawi ZH, Muhammad EM, Noaman HH. Role of immunohistochemical cyclo-oxygenase-2 (COX-2) and osteocalcin in differentiating between osteoblastomas and osteosarcomas. Malays J Pathol 2012;34:15-23.
- Jiao G, Ren T, Lu Q, Sun Y, Lou Z, Peng X, et al. Prognostic significance of cyclooxygenase-2 in osteosarcoma: a meta-analysis. Tumour Biol 2013;34:2489-2495. https://doi.org/10.1007/s13277-013-0998-2
- Boulytcheva IV, Soloviev YN, Kushlinskii NE, Mahson AN. Expression of molecular markers in the tumor and survival prognosis in osteosarcoma. Bull Exp Biol Med 2010;150:237-242. https://doi.org/10.1007/s10517-010-1114-x
- Urakawa H, Nishida Y, Naruse T, Nakashima H, Ishiguro N. Cyclooxygenase-2 overexpression predicts poor survival in patients with high-grade extremity osteosarcoma: a pilot study. Clin Orthop Relat Res 2009;467:2932-2938. https://doi.org/10.1007/s11999-009-0814-x
- Wang Z, He M, Xiao Z, Wu H, Wu Y. Quantitative assessment of the association of COX-2 (cyclooxygenase-2) immunoexpression with prognosis in human osteosarcoma: a metaanalysis. PLoS One 2013;8:e82907. https://doi.org/10.1371/journal.pone.0082907
- Wu X, Cai M, Ji F, Lou LM. The impact of COX-2 on invasion of osteosarcoma cell and its mechanism of regulation. Cancer Cell Int 2014;14:27. https://doi.org/10.1186/1475-2867-14-27
- Zhao Q, Wang C, Zhu J, Wang L, Dong S, Zhang G, et al. RNAi-mediated knockdown of cyclooxygenase2 inhibits the growth, invasion and migration of SaOS2 human osteosarcoma cells: a case control study. J Exp Clin Cancer Res 2011;30:26. https://doi.org/10.1186/1756-9966-30-26
- Sabino MA, Ghilardi JR, Jongen JL, Keyser CP, Luger NM, Mach DB, et al. Simultaneous reduction in cancer pain, bone destruction, and tumor growth by selective inhibition of cyclooxygenase-2. Cancer Res 2002;62:7343-7349.
- Naruse T, Nishida Y, Hosono K, Ishiguro N. Meloxicam inhibits osteosarcoma growth, invasiveness and metastasis by COX-2-dependent and independent routes. Carcinogenesis 2006;27:584-592. https://doi.org/10.1093/carcin/bgi240
- Lee EJ, Choi EM, Kim SR, Park JH, Kim H, Ha KS, et al. Cyclooxygenase-2 promotes cell proliferation, migration and invasion in U2OS human osteosarcoma cells. Exp Mol Med 2007;39:469-476. https://doi.org/10.1038/emm.2007.51
- de Hoon MJ, Imoto S, Nolan J, Miyano S. Open source clustering software. Bioinformatics 2004;20:1453-1454. https://doi.org/10.1093/bioinformatics/bth078
- Saldanha AJ. Java Treeview: extensible visualization of microarray data. Bioinformatics 2004;20:3246-3248. https://doi.org/10.1093/bioinformatics/bth349
- Shoulders MD, Raines RT. Collagen structure and stability. Annu Rev Biochem 2009;78:929-958. https://doi.org/10.1146/annurev.biochem.77.032207.120833
- Li A, Zhou T, Guo L, Si J. Collagen type I regulates beta-catenin tyrosine phosphorylation and nuclear translocation to promote migration and proliferation of gastric carcinoma cells. Oncol Rep 2010;23:1247-1255.
- Zhang K, Corsa CA, Ponik SM, Prior JL, Piwnica-Worms D, Eliceiri KW, et al. The collagen receptor discoidin domain receptor 2 stabilizes SNAIL1 to facilitate breast cancer metastasis. Nat Cell Biol 2013;15:677-687. https://doi.org/10.1038/ncb2743
- Yan Z, Jin S, Wei Z, Huilian H, Zhanhai Y, Yue T, et al. Discoidin domain receptor 2 facilitates prostate cancer bone metastasis via regulating parathyroid hormone-related protein. Biochim Biophys Acta 2014;1842:1350-1363. https://doi.org/10.1016/j.bbadis.2014.04.018
- Xu Z, Choudhary S, Voznesensky O, Mehrotra M, Woodard M, Hansen M, et al. Overexpression of COX-2 in human osteosarcoma cells decreases proliferation and increases apoptosis. Cancer Res 2006;66:6657-6664. https://doi.org/10.1158/0008-5472.CAN-05-3624
- Walmsley MJ, Ooi SK, Reynolds LF, Smith SH, Ruf S, Mathiot A, et al. Critical roles for Rac1 and Rac2 GTPases in B cell development and signaling. Science 2003;302:459-462. https://doi.org/10.1126/science.1089709
- Lucero CM, Vega OA, Osorio MM, Tapia JC, Antonelli M, Stein GS, et al. The cancer-related transcription factor Runx2 modulates cell proliferation in human osteosarcoma cell lines. J Cell Physiol 2013;228:714-723. https://doi.org/10.1002/jcp.24218
- Baniwal SK, Khalid O, Gabet Y, Shah RR, Purcell DJ, Mav D, et al. Runx2 transcriptome of prostate cancer cells: insights into invasiveness and bone metastasis. Mol Cancer 2010;9:258. https://doi.org/10.1186/1476-4598-9-258
- Leong DT, Lim J, Goh X, Pratap J, Pereira BP, Kwok HS, et al. Cancer-related ectopic expression of the bone-related transcription factor RUNX2 in non-osseous metastatic tumor cells is linked to cell proliferation and motility. Breast Cancer Res 2010;12:R89. https://doi.org/10.1186/bcr2762
- Richmond TJ, Davey CA. The structure of DNA in the nucleosome core. Nature 2003;423:145-150. https://doi.org/10.1038/nature01595
- Han M, Grunstein M. Nucleosome loss activates yeast downstream promoters in vivo. Cell 1988;55:1137-1145. https://doi.org/10.1016/0092-8674(88)90258-9
- Lorch Y, LaPointe JW, Kornberg RD. Nucleosomes inhibit the initiation of transcription but allow chain elongation with the displacement of histones. Cell 1987;49:203-210. https://doi.org/10.1016/0092-8674(87)90561-7
- Kim K, Punj V, Choi J, Heo K, Kim JM, Laird PW, et al. Gene dysregulation by histone variant H2A.Z in bladder cancer. Epigenetics Chromatin 2013;6:34. https://doi.org/10.1186/1756-8935-6-34
Cited by
- An Integrative Transcriptomic Analysis for Identifying Novel Target Genes Corresponding to Severity Spectrum in Spinal Muscular Atrophy vol.11, pp.6, 2016, https://doi.org/10.1371/journal.pone.0157426
- Combined analysis of gene expression, miRNA expression and DNA methylation profiles of osteosarcoma vol.37, pp.2, 2016, https://doi.org/10.3892/or.2016.5324
- Analysis of Gene Expression in Human Dermal Fibroblasts Treated with Senescence-Modulating COX Inhibitors vol.15, pp.2, 2017, https://doi.org/10.5808/GI.2017.15.2.56
- Telmisartan Protects a Microglia Cell Line from LPS Injury Beyond AT1 Receptor Blockade or PPARγ Activation pp.1559-1182, 2018, https://doi.org/10.1007/s12035-018-1300-9